We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
WHX Labs Dubai 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Immuno-Capture Technology Optimized for Mass Spectrometer Detection

By Biotechdaily staff writers
Posted on 10 Apr 2007
A next-generation immuno-capture technology has been optimized for mass spectrometer (MS) detection. Immuno-catch is a powerful alternative to slower, low-yield immunoprecipitation assays. The novel technology offers a promise of molecular diagnostics for the detection using standard MS and gel technologies and new capabilities for advanced peptide and protein research.

The new kit consists of streptavidin-coated 96 well microplates and all the necessary buffers for binding and elution from the plate. The streptavidin coating procedure provides a high binding capacity for biotinylated capture agents, including antibodies, but also an extremely robust coating to allow easy elution of captured analytes. These qualities provide a high-throughput, multiplex format for the enrichment of specific target proteins and peptides from complex biological samples (such as blood serum).

PerkinElmer Life and Analytical Sciences (Waltham, MA, USA) developed the new kit, which is called the Immuno-catch kit. In addition to conventional immunoassays of intact proteins, the kit was designed to meet the unique requirements of investigators interested in the low-molecular weight peptidomic environment. Researchers in the emerging discipline of peptidomics are very interested in peptide fragments as important markers of cellular signals and as potential markers of diagnostic information.

PerkinElmer is currently collaborating with Drs. Lance Liotta and Emanuel Petricoin, co-directors of the Center for Applied Proteomics and Molecular Medicine at George Mason University (Fairfax County, VA, USA) for the investigation of possible clinical utility of peptidomics and Immuno-catch. According to Dr Liotta, "The Immuno-catch platform provides a critical component for our ongoing alliance with PerkinElmer to explore the peptidome, which we hypothesize to hold untapped and significant diagnostic potential.

In addition to conventional immunoassays of intact proteins, the Immuno-catch kit was designed to meet the unique requirements of investigators interested in the low-molecular weight peptidomic environment. Researchers in the emerging discipline of peptidomics have great interest in peptide fragments as important markers of cellular signals and as potential markers of diagnostic information.


Related Links:
PerkinElmer

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
ESR Analyzer
TEST1 2.0

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
10 Apr 2007  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
10 Apr 2007  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
10 Apr 2007  |   BioResearch